Olivia Rodrigo’s “The Cure” leads the 2026 VMA Best Alternative market at a 64.5% implied probability because the track and its inventive, handcrafted video have generated the strongest industry and fan momentum among the seven nominees. Rodrigo’s third album delivered the song as a self-reflective highlight, earning critical praise for its emotional depth and orchestral build, while a dedicated Grammy Museum exhibition underscores its cultural resonance just before the Sept. 27 ceremony. The other contenders—Twenty One Pilots’ “Drag Path,” Noah Kahan’s “The Great Divide,” Tame Impala’s “Dracula,” and smaller entries like Geese’s “Taxes”—sit at far lower odds, reflecting narrower mainstream crossover and fewer recent catalysts. With fan voting closing Sept. 25, traders are pricing in Rodrigo’s broad appeal and late visibility as decisive factors in this closely watched category.